Impact of HAART on the clinical management of AIDS-related cancers
- 1 July 2001
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 37 (10) , 1320-1324
- https://doi.org/10.1016/s0959-8049(01)00106-x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: biological correlates of clinical outcomeEuropean Journal Of Cancer, 1999
- Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi‚s sarcomaAIDS, 1999
- AIDS-related lymphomaBlood Reviews, 1999
- AIDS-related malignanciesCurrent Opinion in Oncology, 1998
- Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposiʼs sarcomaAIDS, 1998
- DECLINING INCIDENCE OF KAPOSI'S SARCOMA IN AIDS CLINICAL TRIAL GROUP (ACTG) TRIALSJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
- Impact of Ilighly Effective Anti-retroviral Therapy on the Incidence of Malignancies Among HIV-infected IndividualsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapyAIDS, 1997
- Reduction of Kaposiʼs sarcoma lesions following treatment of AIDS with ritonovirAIDS, 1997